Form D · Biotechnology
Ischemix LLC
Maynard, MA · CIK 0001610067
Offering snapshot reported Jun 5, 2014 · SEC filing
- Reported sold
- $6.6M Offering amount: $6.6M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 21, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 5, 2014 | Initial | $6,600,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-218610
Source: Form D, filed Jun 5, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Reinier Beeuwkes | Director |
| Geoffrey Clark | Director |
| David De Wahl, Jr. | Director, Executive |
| John Norris | Director |
| Edward Shashoua | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
63 Great Road
Maynard, MA, 01754
Maynard, MA, 01754